Migraine in Primary Care: Which Patients are at Risk?

News
Slideshow

Results from a recent analysis of trends in US migraine prevalence show disease burden higher in populations that may be neglected. Are any of your patients at risk? 

Migraines are widespread in the US and also concentrated in defined populations. Results of a recent analysis of trends in disease burden and distribution were published in the most recent edition of the journal Headache.Are any of your patients in a population disproportionately affected by migraine? Scan through the short slide show above for information that could help improve primary intervention.For more information: Burch R, Rizzoli P, Loder E, et al. The Prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache. 2018; 58:496-505. 

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Related Content
Digital Latency Measures Refine Early Detection of Cognitive Decline: Review of Evidence / image credit Rowan University

Digital Latency Measures Refine Early Detection of Cognitive Decline: Expert Review of Evidence

Grace Halsey
July 17th 2025
Article

Digital latency measures enhance early detection of cognitive decline, revealing neurodegenerative changes before traditional tests indicate impairment.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Quest Will Offer FDA-Cleared Fujirebio Blood Test to Detect Alzheimer Disease / image courtesy of Quest Diagnostics

Quest Will Offer FDA-Cleared Fujirebio Blood Test to Detect Alzheimer Disease

Grace Halsey
July 9th 2025
Article

The Fujirebio in-vitro diagnostic has shown positive and negative predictive values of 92% and 97%, respectively, for early AD detection and will be offered by end of summer.

Distress Signals: How to Help a Clinician Colleague in Need

Distress Signals: How to Help a Clinician Colleague in Need

Sydney Jennings
February 14th 2023
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

Adjuvanted Vaccines Against Shingles, RSV Associated with Reduced Risk of Dementia, New Study Shows

Adjuvanted Vaccine Against RSV Associated with Substantial Reduced Risk of Dementia

Grace Halsey
June 30th 2025
Article

The adjuvanted RSV vaccine, in particular, was associated with a 29% reduction in the risk of dementia in the subsequent 18 months, a University of Oxford study found.

Only Half of Adults Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results / image credit ©Speedkings/Shutterstock.com

Only Half of Patients Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results

Grace Halsey
June 26th 2025
Article

Suboptimal adherence with antidementia drugs is associated with poorer clinical outcomes including accelerated disease progression and symptomatology.

© 2025 MJH Life Sciences

All rights reserved.